These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35275541)

  • 1. Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial.
    Krause-Sorio B; Siddarth P; Kilpatrick L; Milillo MM; Aguilar-Faustino Y; Ercoli L; Narr KL; Khalsa DS; Lavretsky H
    J Alzheimers Dis; 2022; 87(2):569-581. PubMed ID: 35275541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease.
    Kilpatrick LA; Siddarth P; Krause-Sorio B; Milillo MM; Aguilar-Faustino Y; Ercoli L; Narr KL; Khalsa DS; Lavretsky H
    J Alzheimers Dis; 2023; 95(1):149-159. PubMed ID: 37482992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer's disease.
    Grzenda A; Siddarth P; Milillo MM; Aguilar-Faustino Y; Khalsa DS; Lavretsky H
    Transl Psychiatry; 2024 Feb; 14(1):96. PubMed ID: 38355715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Odor identification deficit in mild cognitive impairment and Alzheimer's disease is associated with hippocampal and deep gray matter atrophy.
    Hagemeier J; Woodward MR; Rafique UA; Amrutkar CV; Bergsland N; Dwyer MG; Benedict R; Zivadinov R; Szigeti K
    Psychiatry Res Neuroimaging; 2016 Sep; 255():87-93. PubMed ID: 27567325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled trial of Kundalini yoga in mild cognitive impairment.
    Eyre HA; Siddarth P; Acevedo B; Van Dyk K; Paholpak P; Ercoli L; St Cyr N; Yang H; Khalsa DS; Lavretsky H
    Int Psychogeriatr; 2017 Apr; 29(4):557-567. PubMed ID: 28088925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain Gray Matter Volume Mediated the Correlation Between Plasma P-Tau and Cognitive Function of Early Alzheimer's Disease in China: A Cross-Sectional Observational Study.
    Wan K; Yin W; Tang Y; Zhu W; Wang Z; Zhou X; Zhang W; Zhang C; Yu X; Zhao W; Li C; Zhu X; Sun Z
    J Alzheimers Dis; 2023; 92(1):81-93. PubMed ID: 36710682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
    Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
    Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered mismatch response precedes gray matter atrophy in subjective cognitive decline.
    Cheng CH; Chang CC; Chao YP; Lu H; Peng SW; Wang PN
    Psychophysiology; 2021 Jun; 58(6):e13820. PubMed ID: 33792049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between white matter hyperintensity load and grey matter atrophy in mild cognitive impairment is not unidirectional.
    Vipin A; Wong BYX; Kumar D; Low A; Ng KP; Kandiah N
    Aging (Albany NY); 2021 Apr; 13(8):10973-10988. PubMed ID: 33861727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smaller grey matter volume in the central olfactory system in mild cognitive impairment.
    Jobin B; Boller B; Frasnelli J;
    Exp Gerontol; 2023 Nov; 183():112325. PubMed ID: 37952649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional and structural alterations of dorsal attention network in preclinical and early-stage Alzheimer's disease.
    Wu H; Song Y; Yang X; Chen S; Ge H; Yan Z; Qi W; Yuan Q; Liang X; Lin X; Chen J
    CNS Neurosci Ther; 2023 Jun; 29(6):1512-1524. PubMed ID: 36942514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.
    Sui X; Rajapakse JC;
    Neuroimage Clin; 2018; 20():1222-1232. PubMed ID: 30412925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.